Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Depreciation & Amortization (CF) (2016 - 2025)

Traws Pharma's Depreciation & Amortization (CF) history spans 14 years, with the latest figure at $44000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $44000.0 for Q4 2025, up 2100.0% from a year ago — trailing twelve months through Dec 2025 was $61000.0 (up 408.33% YoY), and the annual figure for FY2025 was $61000.0, up 408.33%.
  • Depreciation & Amortization (CF) for Q4 2025 was $44000.0 at Traws Pharma, up from $15000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $44000.0 in Q4 2025 to a low of $1000.0 in Q1 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $4000.0 (2021), against an average of $5850.0.
  • Peak annual rise in Depreciation & Amortization (CF) hit 2100.0% in 2025, while the deepest fall reached 75.0% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $4000.0 in 2021, then changed by 0.0% to $4000.0 in 2022, then changed by 0.0% to $4000.0 in 2023, then tumbled by 50.0% to $2000.0 in 2024, then skyrocketed by 2100.0% to $44000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $44000.0, $15000.0, and $1000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.